How Media Coverage of Oral Minoxidil for Hair Loss Has Impacted Prescribing Habits

    June 2024 in “ Cutis
    Drew Taylor, Mary Michael, Tam H. Nguyen, Kyle C. Lauck, Kelly K Park, Stanislav N. Tolkachjov, Eduardo Weiss
    TLDR Media coverage led to more dermatologists prescribing low-dose oral minoxidil for hair loss.
    The publication of a New York Times article in August 2022 significantly influenced the prescribing habits of dermatologists regarding low-dose oral minoxidil (LDOM) for hair loss. A survey of 65 US-based board-certified dermatologists revealed that 42% began prescribing or increased their use of LDOM following the article. Data from Epiphany Dermatology and Summit Pharmacy showed substantial increases in LDOM prescriptions post-publication, with Epiphany Dermatology reporting 1,377 prescriptions in the 8 months following the article. Studies have shown LDOM to be a safe and effective treatment for alopecia, with minimal adverse effects. This highlights the powerful impact media coverage can have on medical practices and patient inquiries.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    8 / 8 results